QoL and Cognitive Function in Patients With Hypoparathyroidism

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

October 1, 2020

Study Completion Date

December 1, 2021

Conditions
HypoparathyroidismPseudo Hypoparathyroidism
Interventions
DIAGNOSTIC_TEST

MRI scans

Contrast-enhanced, magnetic resonance imaging (MRI) based method to detect disturbances in microvascular flow patterns in the human brain

DIAGNOSTIC_TEST

Neuro cognitive tests

Standard neuropsychological test battery consists of validated tests to assess cognitive domains including verbal and visual memory, attention, language, visuospatial and executive functioning.

DIAGNOSTIC_TEST

Questionnaires on Quality of Life

SF36v2, WHO-5 well-being index, HPQ28, Symptom questionnaire, and a general questionnaire on background information, medication and diet.

DIAGNOSTIC_TEST

Blood samples

Markers of calcium homeostasis, inflammatory markers and hematology.

DIAGNOSTIC_TEST

24 hr urine samples

24 hr urine content of calcium, phosphate, magnesium, and creatinine.

Trial Locations (1)

8200

Clinic for Osteoporosis, Aarhus University Hospital, Aarhus N

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT04569604 - QoL and Cognitive Function in Patients With Hypoparathyroidism | Biotech Hunter | Biotech Hunter